Knappertz Volker 4
4 · Aurinia Pharmaceuticals Inc. · Filed Aug 1, 2022
Insider Transaction Report
Form 4
Knappertz Volker
EVP, Research and Development
Transactions
- Award
Stock Option (right to buy)
2022-08-01+256,892→ 256,892 totalExercise: $8.18Exp: 2032-08-01→ Common Stock (256,892 underlying) - Award
Restricted Stock Units
2022-08-01+152,812→ 152,812 total→ Common Shares (152,812 underlying)
Footnotes (2)
- [F1]One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in three (3) equal annual installments beginning August 1, 2023.